Journal of Cancer Research and Therapeutics Close
 

Figure 2: Gemcitabine increased the 125I-induced antiproliferation effect cells were treated with 125I, gemcitabine or concurrent 125I and gemcitabine. At a dose of 4 Gy, antiproliferation assay (a), colony formation assay (b) and cell cycle analysis (c and d) were used to analyze the antiproliferation effect. All experiments were performed in triplicate, and the data are presented as the mean ± standard deviation. The t-test was used for data analysis. *P < 0.05, **P < 0.01

Figure 2: Gemcitabine increased the <sup>125</sup>I-induced antiproliferation effect cells were treated with <sup>125</sup>I, gemcitabine or concurrent <sup>125</sup>I and gemcitabine. At a dose of 4 Gy, antiproliferation assay (a), colony formation assay (b) and cell cycle analysis (c and d) were used to analyze the antiproliferation effect. All experiments were performed in triplicate, and the data are presented as the mean ± standard deviation. The <i>t</i>-test was used for data analysis. *<i>P</i> < 0.05, **<i>P</i> < 0.01